semaglutide cv outcomes SELECT Trial semaglutide cardiovascular trial New Science

Our lab aims to develop a biomimetic nonviral oral gene delivery platform by loading OMVs derived from commensal gut bacteria with therapeutic plasmid DNA to create nanocarriers capable of protecting nucleic acids and transfecting gut cells

With careful portion control, butter can still have a place in your weight loss plan

While transdermal delivery remains an area of research interest, the practical challenges of delivering peptide molecules across skin barriers have slowed development

What are the symptoms of L-carnitine deficiency

Read safety information Supporting research A selection of peer-reviewed work on GHK-Cu/Epitalon